Maria Gagliardi
Papers
1
Total Citations
22
H-Index
1
About
Maria Gagliardi is a dedicated translational researcher whose work centers on the aggressive and poorly understood realm of inflammatory breast cancer (IBC). Her primary contributions lie in developing clinically relevant models to study this lethal disease, which carries a stark 62-68% five-year survival rate. Her most cited paper, a 2018 study on patient-derived xenograft ex vivo models, provides a critical platform for evaluating tumor-specific therapies, directly addressing the urgent need for better treatment strategies. By creating these sophisticated models, Gagliardi enables researchers to test drug efficacy in a setting that closely mimics human tumor biology, bridging a crucial gap between basic science and clinical application. Her work is not merely academic; it is a direct assault on the poor prognosis of IBC, aiming to improve early detection and therapeutic outcomes. With her models gaining traction in the field—evidenced by over 20 citations on this foundational work alone—Gagliardi is establishing herself as a key figure in the fight against one of breast cancer’s most formidable forms, offering new hope for patients and a powerful tool for the research community.
Research Focus
Key Achievements
Top Papers
- 1